A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy

Here we report the case of a 30-year-old woman with relapsed acute myeloid leukemia (AML) who was treated with all-trans retinoic acid (ATRA) as part of investigational therapy (NCT02273102). The patient died from rapid disease progression following eight days of continuous treatment with ATRA. Kary...

Descripción completa

Detalles Bibliográficos
Autores principales: Watts, Justin M., Perez, Aymee, Pereira, Lutecia, Fan, Yao-Shan, Brown, Geoffrey, Vega, Francisco, Petrie, Kevin, Swords, Ronan T., Zelent, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535982/
https://www.ncbi.nlm.nih.gov/pubmed/28696354
http://dx.doi.org/10.3390/ijms18071492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535982/
https://www.ncbi.nlm.nih.gov/pubmed/28696354
http://dx.doi.org/10.3390/ijms18071492

Ejemplares similares